Sign in
4

Changes in Ownership

Nuvectis Pharma, Inc. Filed Acc 0001104659-22-129348

Chief Dev. & Ops. Officer bought 500 shares at $7.65 ($3,825)

From the SEC's structured data for this filing

Trades in this filing

Shemesh Shay · Chief Dev. & Ops. Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-12-21 Purchase : show line 1 in the form +500 $7.65 $3,825 1,245,865 D
Open-market purchases · 500 sh · avg $7.65 · $3,825
Loading xslF345X03/tm2233335-1_4seq1.xml…